Synthesis, Antimicrobial Evaluation, and Docking Studies of Substituted New Chromone Linked 1,2,3-Triazoles

References

• R. P. N. Mishra, E. Oviedo-Orta, P. Prachi, R. Rappuoli, and F. Bagnoli, “Vaccines and Antibiotic Resistance,” Current Opinion in Microbiology 15, no. 5 (2012): 596–602. doi:10.1016/j.mib.2012.08.002
   PubMed Web of Science ®Google Scholar
• V. Gandhi, and W. Plunkett, “Cellular and Clinical Pharmacology of Fludarabine,” Clinical Pharmacokinetics 41, no. 2 (2002): 93–103. doi:10.2165/00003088-200241020-00002
   PubMed Web of Science ®Google Scholar
• T. Konno, T. Daitoh, A. Noiri, J. Chae, T. Ishihara, and H. Yamanaka, “A Highly Regio- and Stereoselective Carbocupration of Fluoroalkylated Internal Alkynes: A Short Total Synthesis of the Antiestrogenic Drug Panomifene,” Organic Letters 6, no. 6 (2004): 933–936. doi:10.1021/ol036440n
   PubMed Web of Science ®Google Scholar
• A. Woollard, and Publishers, S. '' An unusual column effect during the analysis of Cfluorocytosine high-performance liquid chromatography,'' Journal of chromatography. 368, (1986):162–163.
   Google Scholar
• J. L. Berk, O. B. Suhr, L. Obici, Y. Sekijima, S. R. Zeldenrust, T. Yamashita, M. A. Heneghan, P. D. Gorevic, W. J. Litchy, J. F. Wiesman, et al. “Repurposing Diflunisal for Familial Amyloid Polyneuropathy: A Randomized Clinical Trial,” Jama 310, no. 24 (2013): 2658–2667. doi:10.1001/jama.2013.283815
   PubMed Web of Science ®Google Scholar
• J. H. Rex, M. A. Pfaller, A. L. Barry, P. W. Nelson, and C. D. Webb, “Resistance of Candida Species to Fluconazole,” Antimicrobial Agents and Chemotherapy 39, no. 1 (1995): 40–44. doi:10.1128/aac.39.1.1
   PubMed Web of Science ®Google Scholar
• S. S. Sutton, “Voriconazole: A New Triazole Antifungal Agent,” P and T 28, no. 4 (2003): 268–275.
   Google Scholar
• Peter, K. Christopher, Murtaugh, and M. The New England Journal of Medicine Downloaded from Nejm.Org on January 12, 2022. For Personal Use Only. No Other Uses without Permission. Copyright © 1991 Massachusetts Medical Society. All Rights Reserved. 1999.
   Google Scholar
• C. K. Jadhav, A. S. Nipate, A. V. Chate, V. D. Songire, A. P. Patil, and C. H. Gill, “Efficient Rapid Access to Biginelli for the Multicomponent Synthesis of 1,2,3,4-Tetrahydropyrimidines in Room-Temperature Diisopropyl Ethyl Ammonium Acetate,” ACS Omega 4, no. 27 (2019): 22313–22324. doi:10.1021/acsomega.9b02286
   PubMed Web of Science ®Google Scholar
• A. V. Chate, S. P. Kamdi, A. N. Bhagat, C. K. Jadhav, A. Nipte, A. P. Sarkate, S. V. Tiwari, and C. H. Gill, “Design, Synthesis and SAR Study of Novel Spiro [Pyrimido[5,4-b]Quinoline-10,5′-Pyrrolo[2,3-d]Pyrimidine] Derivatives as Promising Anticancer Agents,” Journal of Heterocyclic Chemistry 55, no. 10 (2018): 2297–2302. doi:10.1002/jhet.3286
   Web of Science ®Google Scholar
• A. Gaspar, M. J. Matos, J. Garrido, E. Uriarte, and F. Borges, “Chromone: A Valid Scaffold in Medicinal Chemistry,” Chemical Reviews 114, no. 9 (2014): 4960–4992. doi:10.1021/cr400265z
   PubMed Web of Science ®Google Scholar
• C. Chiruta, D. Schubert, R. Dargusch, and P. Maher, “Chemical Modification of the Multitarget Neuroprotective Compound Fisetin,” Journal of Medicinal Chemistry 55, no. 1 (2012): 378–389. doi:10.1021/jm2012563
   PubMed Web of Science ®Google Scholar
• N. Desideri, P. Mastromarino, and C. Conti, “Synthesis and Evaluation of Antirhinovirus Activity of 3-Hydroxy and 3-Methoxy 2-Styrylchromones,” Antiviral Chemistry & Chemotherapy 14, no. 4 (2003): 195–203. pp doi:10.1177/095632020301400404
   PubMedGoogle Scholar
• S. T. Chung, W. H. Huang, C. K. Huang, F. C. Liu, R. Y. Huang, C. C. Wu, and A. R. Lee, “Synthesis and anti-Inflammatory Activities of 4H-Chromene and Chromeno[2,3-b]Pyridine Derivatives,” Research on Chemical Intermediates 42, no. 2 (2016): 1195–1215. doi:10.1007/s11164-015-2081-7
   Web of Science ®Google Scholar
• S. Vogel, M. Barbic, G. Jürgenliemk, and J. Heilmann, “Synthesis, Cytotoxicity, anti-Oxidative and anti-Inflammatory Activity of Chalcones and Influence of A-Ring Modifications on the Pharmacological Effect,” European Journal of Medicinal Chemistry 45, no. 6 (2010): 2206–2213. doi:10.1016/j.ejmech.2010.01.060
   PubMed Web of Science ®Google Scholar
• A. Gaspar, M. Mohabbati, F. Cagide, N. Razzaghi-Asl, R. Miri, O. Firuzi, and F. Borges, “Searching for New Cytotoxic Agents Based on Chromen-4-One and Chromane-2,4-Dione Scaffolds,” Research in Pharmaceutical Sciences 14, no. 1 (2019): 74–83. doi:10.4103/1735-5362.251855
   PubMed Web of Science ®Google Scholar
• V. S. Dofe, A. P. Sarkate, Z. M. Shaikh, C. K. Jadhav, A. S. Nipte, and C. H. Gill, “Ultrasound-Assisted Synthesis of Novel Pyrazole and Pyrimidine Derivatives as Antimicrobial Agents,” Journal of Heterocyclic Chemistry 55, no. 3 (2018): 756–762. doi:10.1002/jhet.3105
   Web of Science ®Google Scholar
• C. K. Jadhav, A. S. Nipate, A. V. Chate, A. P. Patil, and C. H. Gill, “Ionic Liquid Catalyzed One-Pot Multi-Component Synthesis of Fused Pyridine Derivatives: A Strategy for Green and Sustainable Chemistry,” Journal of Heterocyclic Chemistry 57, no. 12 (2020): 4291–4303. doi:10.1002/jhet.4135
   Web of Science ®Google Scholar
• H. C. Kolb, M. G. Finn, and K. B. Sharpless, “Click Chemistry: Diverse Chemical Function from a Few Good Reactions,” Angewandte Chemie International Edition 40, no. 11 (2001): 2004–2021. doi:10.1002/1521-3773(20010601)40:11<2004::AID-ANIE2004>3.0.CO;2-5
   PubMed Web of Science ®Google Scholar
• V. V. Rostovtsev, L. G. Green, V. V. Fokin, and K. B. Sharpless, “A Stepwise Huisgen Cycloaddition Process: Copper(I)-Catalyzed Regioselective “Ligation” of Azides and Terminal Alkynes - Rostovtsev - 2002 - Angewandte Chemie - Wiley Online Library,” Angewandte Chemie 114, no. 14 (2002): 2708–2711. doi:10.1002/1521-3757(20020715)114:14<2708::AID-ANGE2708>3.0.CO;2-0
   Google Scholar
• M. Allam, A. K. D. Bhavani, A. Mudiraj, N. Ranjan, M. Thippana, and P. P. Babu, “Synthesis of Pyrazolo[3,4-d]Pyrimidin-4(5H)-Ones Tethered to 1,2,3-Triazoles and Their Evaluation as Potential Anticancer Agents,” European Journal of Medicinal Chemistry 156 (2018): 43–52. doi:10.1016/j.ejmech.2018.06.055
   PubMed Web of Science ®Google Scholar
• S. Arroyo, “Rufinamide,” Neurotherapeutics : The Journal of the American Society for Experimental NeuroTherapeutics 4, no. 1 (2007): 155–162. doi:10.1016/j.nurt.2006.11.006
   PubMed Web of Science ®Google Scholar
• G. R. Oxnard, J. C.-H. Yang, H. Yu, S.-W. Kim, H. Saka, L. Horn, K. Goto, Y. Ohe, H. Mann, K. S. Thress, et al. “TATTON: A Multi-Arm, Phase Ib Trial of Osimertinib Combined with Selumetinib, Savolitinib, or Durvalumab in EGFR-Mutant Lung Cancer,” Annals of Oncology : Official Journal of the European Society for Medical Oncology 31, no. 4 (2020): 507–516. ;. doi:10.1016/j.annonc.2020.01.013
   PubMed Web of Science ®Google Scholar
• P. P. Dobesh, and J. H. Oestreich, “Ticagrelor: Pharmacokinetics, Pharmacodynamics, Clinical Efficacy, and Safety,” Pharmacotherapy 34, no. 10 (2014): 1077–1090. doi:10.1002/phar.1477
   PubMed Web of Science ®Google Scholar
• D. R. Giacobbe, M. Bassetti, F. G. De Rosa, V. Del Bono, P. A. Grossi, F. Menichetti, F. Pea, G. M. Rossolini, M. Tumbarello, P. Viale, et al. “Ceftolozane/Tazobactam: Place in Therapy,” Expert Review of anti-Infective Therapy 16, no. 4 (2018): 307–320. doi:10.1080/14787210.2018.1447381
   PubMed Web of Science ®Google Scholar
• C. W. Tornøe, C. Christensen, and M. Meldal, “Peptidotriazoles on Solid Phase: [1,2,3]-Triazoles by Regiospecific Copper(I)-Catalyzed 1,3-Dipolar Cycloadditions of Terminal Alkynes to Azides,” The Journal of Organic Chemistry 67, no. 9 (2002): 3057–3064. doi:10.1021/jo011148j
   PubMed Web of Science ®Google Scholar
• C. Lass-Flörl, “Triazole Antifungal Agents in Invasive Fungal Infections: A Comparative Review,” Drugs 71, no. 18 (2011): 2405–2419. doi:10.2165/11596540-000000000-00000
   PubMed Web of Science ®Google Scholar
• S. Shafi, M. Mahboob Alam, N. Mulakayala, C. Mulakayala, G. Vanaja, A. M. Kalle, R. Pallu, and M. S. Alam, “Synthesis of Novel 2-Mercapto Benzothiazole and 1,2,3-Triazole Based Bis-Heterocycles: Their Anti-Inflammatory and Anti-Nociceptive Activities,” European Journal of Medicinal Chemistry 49 (2012): 324–333. doi:10.1016/j.ejmech.2012.01.032
   PubMed Web of Science ®Google Scholar
• M.H.Shaikh, D. D. Subhedar, L. Nawale, D. Sarkar, F. A. K. Khan, J. N. Sangshetti, and, B. B. Shingate. "1, 2, 3-Triazole derivatives as antitubercular agents: synthesis, biological evaluation and molecular docking study." MedChemComm 6, no. 6 (2015): 1104–1116.
   Google Scholar
• A. K. Jordão, V. F. Ferreira, E. S. Lima, M. C. B. V. de Souza, E. C. L. Carlos, H. C. Castro, R. B. Geraldo, C. R. Rodrigues, M. C. B. Almeida, and A. C. Cunha, “Synthesis, Antiplatelet and in Silico Evaluations of Novel N-Substituted-Phenylamino-5-Methyl-1H-1,2,3-Triazole-4-Carbohydrazides,” Bioorganic & Medicinal Chemistry 17, no. 10 (2009): 3713–3719. doi:10.1016/j.bmc.2009.03.053
   PubMed Web of Science ®Google Scholar
• A. S. Nipate, C. K. Jadhav, A. V. Chate, T. R. Deshmukh, A. P. Sarkate, and C. H. Gill, “Synthesis and in Vitro Anticancer Activities of New 1,4-Disubstituted-1,2,3-Triazoles Derivatives through Click Approach,” ChemistrySelect 6, no. 21 (2021): 5173–5179. doi:10.1002/slct.202101035
   Web of Science ®Google Scholar
• Babita Aneja, Rizwan Arif, Ahmad Perwez, John V. Napoleon, Phool Hasan, M. Moshahid A. Rizvi, Amir Azam, and Mohammad Abid, Rahisuddin, “N-Substituted 1,2,3-Triazolyl-Appended Indole-Chalcone Hybrids as Potential DNA Intercalators Endowed with Antioxidant and Anticancer Properties,” ChemistrySelect 3, no. 9 (2018): 2638–2645. doi:10.1002/slct.201702913
   Web of Science ®Google Scholar
• M. B. Muluk, S. T. Dhumal, P. S. Phatak, N. N. M. A. Rehman, P. P. Dixit, P. B. Choudhari, R. A. Mane, and K. P. Haval, “Synthesis, Antimicrobial Activity, and Molecular Docking Study of Formylnaphthalenyloxymethyl-Triazolyl-N-Phenylacetamides,” Journal of Heterocyclic Chemistry 56, no. 9 (2019): 2411–2418. doi:10.1002/jhet.3628
   Web of Science ®Google Scholar
• V. S. Dofe, A. P. Sarkate, D. K. Lokwani, S. H. Kathwate, and C. H. Gill, “Synthesis, Antimicrobial Evaluation, and Molecular Docking Studies of Novel Chromone Based 1,2,3-Triazoles,” Research on Chemical Intermediates 43, no. 1 (2017): 15–28. doi:10.1007/s11164-016-2602-z
   Web of Science ®Google Scholar
• C. Moberg, and H. Adolfsson, "Aryl Azides'' Compounds of Groups 15 (as, Sb, Bi) and Silicon Compounds 45 (2002). doi:10.1055/sos-sd-004-00481
   Google Scholar